CN110089751A - Intestines arrange health care product - Google Patents
Intestines arrange health care product Download PDFInfo
- Publication number
- CN110089751A CN110089751A CN201910260830.0A CN201910260830A CN110089751A CN 110089751 A CN110089751 A CN 110089751A CN 201910260830 A CN201910260830 A CN 201910260830A CN 110089751 A CN110089751 A CN 110089751A
- Authority
- CN
- China
- Prior art keywords
- powder
- health care
- care product
- chamber
- intestines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 43
- 210000000936 intestine Anatomy 0.000 title claims abstract description 42
- 239000000203 mixture Substances 0.000 claims abstract description 39
- 241000209140 Triticum Species 0.000 claims abstract description 24
- 235000021307 Triticum Nutrition 0.000 claims abstract description 24
- 108090000790 Enzymes Proteins 0.000 claims abstract description 16
- 102000004190 Enzymes Human genes 0.000 claims abstract description 16
- 244000299461 Theobroma cacao Species 0.000 claims abstract description 14
- 235000009470 Theobroma cacao Nutrition 0.000 claims abstract description 14
- 239000002131 composite material Substances 0.000 claims abstract description 12
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000013618 yogurt Nutrition 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 74
- 244000179886 Moringa oleifera Species 0.000 claims description 21
- 235000011347 Moringa oleifera Nutrition 0.000 claims description 21
- CAXNYFPECZCGFK-UHFFFAOYSA-N 2-phenyl-2-pyridin-2-ylacetonitrile Chemical compound C=1C=CC=NC=1C(C#N)C1=CC=CC=C1 CAXNYFPECZCGFK-UHFFFAOYSA-N 0.000 claims description 20
- 235000010469 Glycine max Nutrition 0.000 claims description 20
- 241000736199 Paeonia Species 0.000 claims description 20
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 20
- 235000012054 meals Nutrition 0.000 claims description 19
- 229920001202 Inulin Polymers 0.000 claims description 18
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 18
- 229940029339 inulin Drugs 0.000 claims description 18
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 15
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 15
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 14
- 240000007087 Apium graveolens Species 0.000 claims description 13
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 13
- 235000010591 Appio Nutrition 0.000 claims description 13
- 235000013312 flour Nutrition 0.000 claims description 11
- 235000007119 Ananas comosus Nutrition 0.000 claims description 10
- 241000207199 Citrus Species 0.000 claims description 10
- 235000020971 citrus fruits Nutrition 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 8
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- 229920002774 Maltodextrin Polymers 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- 244000099147 Ananas comosus Species 0.000 claims description 7
- 241001608472 Bifidobacterium longum Species 0.000 claims description 7
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 7
- 235000005979 Citrus limon Nutrition 0.000 claims description 6
- 244000131522 Citrus pyriformis Species 0.000 claims description 6
- 235000013361 beverage Nutrition 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 2
- 238000010899 nucleation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 36
- 231100000614 poison Toxicity 0.000 abstract description 8
- 239000002574 poison Substances 0.000 abstract description 6
- 239000000470 constituent Substances 0.000 abstract description 5
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 238000010926 purge Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 13
- 235000013305 food Nutrition 0.000 description 13
- 241000282414 Homo sapiens Species 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 10
- 235000013325 dietary fiber Nutrition 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 8
- 229930003268 Vitamin C Natural products 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 235000019154 vitamin C Nutrition 0.000 description 8
- 239000011718 vitamin C Substances 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 240000001046 Lactobacillus acidophilus Species 0.000 description 7
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 235000001465 calcium Nutrition 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 235000007686 potassium Nutrition 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 210000001072 colon Anatomy 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000006041 probiotic Substances 0.000 description 4
- 235000018291 probiotics Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 241000234671 Ananas Species 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000003183 carcinogenic agent Substances 0.000 description 3
- -1 carrotene Chemical compound 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000008855 peristalsis Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- XXLFLUJXWKXUGS-UHFFFAOYSA-N 6-methoxyquinoline-4-carboxylic acid Chemical compound N1=CC=C(C(O)=O)C2=CC(OC)=CC=C21 XXLFLUJXWKXUGS-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- 108010004032 Bromelains Proteins 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241001127637 Plantago Species 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 108010038836 acidolin Proteins 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 235000019835 bromelain Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000000112 colonic effect Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000014786 phosphorus Nutrition 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 235000021391 short chain fatty acids Nutrition 0.000 description 2
- 150000004666 short chain fatty acids Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010041277 Sodium retention Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001745 anti-biotin effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 235000021407 appetite control Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000007784 diverticulitis Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The embodiment of the invention discloses a kind of intestines to arrange health care product.The intestines row health care product is made of first chamber, second chamber and third composition.Wherein, the first chamber is wheat seedling composite enzyme, and the second chamber is cocoa composite enzyme, and the third composition is yogurt composite enzyme.The intestines row health care product by it is a variety of have effects that good bioactivity and natural constituents between cooperate, can obtain good gut purge with discharge toxin effect.In addition, intestines row's health care product fundamentally can treat and be discharged intestines poison, and as health care product, it will not generate and have no toxic side effect taking for a long time, have a good application prospect.Further, which arranges health care product with three kinds of compositions, is encapsulated in laminated aluminum film, is highly convenient for user and takes in daily life, is easy to use.
Description
Technical field
The present invention relates to health product technology fields more particularly to a kind of intestines to arrange health care product.
Background technique
Large intestine and kidney, lungs, the four big excretory organs that skin is human body, while organ -- liver has thousand with removing toxic substances
The connection of ten thousand threads of silk.A large amount of bacterium, its catabolite and a large amount of harmful substance are present in excrement.Not such as excrement
It can be discharged on time, these harmful substance parts can be absorbed by colonic mucosa, entered liver by venous system, aggravated liver
Burden, exhaust the detoxication enzyme system of liver, damage liver function.In addition, pernicious gas enters hepatic effects lung function, and produce
Raw halitosis, while can also aggravate the excretion burden of kidney and skin.
Meanwhile large intestine carries the shedding virus of human body 85%, if enterotoxin cannot excrete in time, can pass through
Intestinal mucosa is deep into blood, enters corporal parts with blood circulation.Color spot, small pox are all presentation, this when
Liver and gallbladder, kidney are all violated.Therefore, intestines poison is source of ten thousand diseases, often clears up the basic guarantee that intestines poison is human health.
In the implementation of the present invention, it is found by the applicant that the prior art has the following technical problems: in order to guarantee human body
Health, occur on the market many for clearing up the drugs of enteron aisle.In addition, hospital is also provided with corresponding enema method.
But existing enteron aisle method for cleaning, these can not fundamentally be treated, can only temporary relief human body discomfort, it is also adjoint
There is some more serious side effects (such as diarrhea, abdominal pain, enteron aisle mechanical damage etc.).
Summary of the invention
In view of the above technical problems, the embodiment of the invention provides a kind of intestines to arrange health care product, to solve present enteron aisle cleaning
The problem of drug can not fundamentally treat intestines poison, be easy to produce serious side effects.
The first aspect of the embodiment of the present invention provides a kind of intestines row health care product.Intestines row's health care product by first chamber,
Second chamber and third composition composition；The first chamber is wheat seedling composite enzyme, and the second chamber is
Cocoa composite enzyme, the third composition are yogurt composite enzyme.
Optionally, the first chamber, the second chamber and the third composition are powdered consolidate
Body beverage, individual packages are in aluminium package dress.
Optionally, the first chamber include maltodextrin, wheat seedling, soy meal, soyabean protein powder, leaf of Moringa powder,
Citrus powder and oligofructose.
Optionally, the first chamber further include: celery, inulin and the luxuriant Chinese herbaceous peony shell powder of circle.
Optionally, count by weight percentage, the first chamber is by the following raw material at being grouped as:
Optionally, the second chamber include: cocoa power, the luxuriant Chinese herbaceous peony shell powder of circle, soy meal, leaf of Moringa powder, trehalose,
Wheat flour, inulin, apple powder, soyabean protein powder and pineapple powder.
Optionally, count by weight percentage, the second chamber is by the following raw material at being grouped as:
Optionally, the third composition include: the luxuriant Chinese herbaceous peony shell powder of circle, soy meal, leaf of Moringa powder, wheat flour, trehalose,
Apple powder, soyabean protein powder and lemon powder.
Optionally, the third composition further include: lactobacillus acidophilus and bifidobacterium longum.
Optionally, count by weight percentage, the third composition is by the following raw material at being grouped as:
The technical solution of the embodiment of the present invention provides a kind of intestines row health care product, has good bioactivity by a variety of
It cooperates between the natural constituents of effect, obtain good gut purge and the effect of toxin is discharged.The intestines arrange health care product can be with
Intestines poison is fundamentally treated and be discharged, and as health care product, will not generate and have no toxic side effect taking for a long time, have good
Good application prospect.
Further, which arranges health care product with three kinds of compositions, is encapsulated in laminated aluminum film, is highly convenient for user and exists
It takes, is easy to use in daily life.
Detailed description of the invention
Fig. 1 is one embodiment schematic diagram for the preparation method that intestines provided in an embodiment of the present invention arrange health care product.
Specific embodiment
Following will be combined with the drawings in the embodiments of the present invention, and technical solution in the embodiment of the present invention carries out clear, complete
Site preparation description, it is clear that described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.It is based on
Embodiment in the present invention, those skilled in the art's every other implementation obtained without creative efforts
Example, shall fall within the protection scope of the present invention.
It should be noted that be expressed " being fixed on " another element when element, it can directly on the other element,
Or there may be one or more elements placed in the middle therebetween.When an element is expressed " connection " another element, it can be with
It is directly to another element or there may be one or more elements placed in the middle therebetween.Used in this specification
The orientation or position of the instructions such as term "vertical", "horizontal", "left" and "right", "upper", "lower", "inner", "outside", " bottom "
Relationship is to be based on the orientation or positional relationship shown in the drawings, and is merely for convenience of description of the present invention and simplification of the description, without referring to
Show or imply that signified device or element must have a particular orientation, be constructed and operated in a specific orientation, therefore cannot manage
Solution is limitation of the present invention.In addition, term " first ", " second " etc. are used for description purposes only, and should not be understood as instruction or
Imply relative importance.
Unless otherwise defined, technical and scientific term all used in this specification is led with technology of the invention is belonged to
The normally understood meaning of the technical staff in domain is identical.Used term is only in the description of the invention in this specification
The purpose of description specific embodiment is not intended to the limitation present invention.Term "and/or" used in this specification includes
Any and all combinations of one or more related listed items.In addition, invention described below difference is implemented
Technical characteristic involved in mode can be combined with each other as long as they do not conflict with each other.
" intestines row ", which refers to, excretes intestinal endotoxin, to play the process of health-care effect.In such a way that intestines are arranged,
It can make one to keep fit, play and improve detoxification ability and other effects.
The embodiment of the invention provides a kind of intestines to arrange health care product, and the effect of intestines row may be implemented after taking, fundamentally control
Treat the problem of intestines poison is left.In the present embodiment, intestines row health care product is combined by first chamber, second chamber and third
Object composition.When in use, three kinds of compositions are collocated with each other use.
Wherein, the first chamber is wheat seedling composite enzyme, using wheat seedling as main body, with other natural components
Mixing obtains.The second chamber is cocoa composite enzyme, and the third composition is yogurt composite enzyme.Analogously,
Second chamber is can be used as main body, and third composition and is mixed using the luxuriant Chinese herbaceous peony shell powder of circle and probiotics as main body
Conjunction has other natural components or auxiliary material etc., obtains good using effect with cooperation.
Specifically, the first chamber, the second chamber and the third composition are equal for the ease of using
For powdered solid beverage.These solid beverages according to certain weight, respectively respective individual packages in aluminium package dress into
Row saves.
In actual use, intestines row health care provided in an embodiment of the present invention can be taken using following eating method
Product:
(1) after using this health care product evening before that day 8:00, fasting simultaneously takes a packet ferment powder in advance, helps intestines
Stool is cleared up in road.Certain supper it is not recommended that plenty of meat and fish, should be suitable for it is light based on.
(2) according to instructions of taking shown in following timetable, corresponding composition (every day is taken in the specific time
Intestines row health care product amount be 120g), and finish off last packet after, go to bed.Wherein, each taking when, often
The weight of one packet is 10g~35g.According to every 10g with 300ml, 25 degrees Celsius of warm water below brew ratio, brewed for
Beverage.
1) 8:00 first chamber
2) 9:00 second chamber
3) 10:00 third composition
4) 11:00 first chamber
5) 12:00 second chamber
6) 13:00 third composition
7) 14:00 first chamber
8) 15:00 second chamber
9) 16:00 third composition
10) 17:00 second chamber
11) 18:00 third composition
(3) it should be guaranteed that great quantity of water drinking during toxin expelling, about 5000-6000ml (rushes 300ml containing every packet), big to guarantee
The activity for measuring organized enzyme, obtains significant effect.
It is preferred that the first chamber, the grams of taking each time of second chamber and third composition can be with
Control is in 10g to obtain relatively good effect.
It is, of course, also possible to be adjusted according to everyone actual conditions to the grams taken, take after mixing it with water every time it is more or
The powder of less weight.
Below in conjunction with specific example, the specific of the first chamber, second chamber and third composition is described in detail
Composition and component ratio.
Embodiment 1:
The first chamber include maltodextrin, wheat seedling, soy meal, soyabean protein powder, leaf of Moringa powder, citrus powder,
Oligofructose, celery, inulin and the luxuriant Chinese herbaceous peony shell powder of circle.Wherein, count by weight percentage, the raw material of the first chamber at
Divide ratio as follows:
Maltodextrin 20~35%；Wheat seedling 15~22%；Soy meal 14~23%；Soyabean protein powder 9~10%；Moringa
Leaf powder 9~10%；Citrus powder 5~10%；Oligofructose 5~8%；Celery 4~6%；Inulin 3~6% and the luxuriant Chinese herbaceous peony shell of circle
Powder 1~3%.
According to the needs of actual conditions, those skilled in the art can select collocation within the above range to obtain described the
One composition.
Preferably, count by weight percentage, the first chamber is by the following raw material at being grouped as: maltodextrin 25%；
Wheat seedling 19%；Soy meal 17%；Soyabean protein powder 8%；Leaf of Moringa powder 8%；Citrus powder 7%；Oligofructose 6%；Celery
5%；Inulin 4% and the luxuriant Chinese herbaceous peony shell powder 1% of circle.Amazing discovery, can using the first chamber that said components match
To obtain optimal health-care effect.
Wherein, maltodextrin is a kind of widely used basic material, can more protrude original natural flavour mountaineous, reduction
Nutritive loss improves solubility property, increases consistency, improves mouthfeel, reduces sugariness, reduces cost, increase economic efficiency.For example,
Maltodextrin is added in instant noodles, product taste can be substantially improved, increases kind, reduces cost, increase economic efficiency.
Wheat seedling has an alkalization effect to blood, and alkaline matter abundant helps to reduce blood peracid, it can by with
In alleviating a variety of internal pains, successfully applied to treat peptic ulcer, ulcerative colitis, constipation, diarrhea etc..Separately
Outside, facilitate cytothesis to delaying senility, tighten the skin to have relaxed, achieve the effect that beauty.
Moreover, wheat seedling is rich in natural vitamin A, vitamin C and vitamin E.Wherein, vitamin C is for skin, tooth
Tooth, eyes, muscle, gums etc. are extremely important, also maintain normal growth and the development of people.Vitamin E can be resisted in air
Polluter prevents other vitamins to be destroyed, and can prevent to suffer from bronchitis, safeguard lung health.
In soy meal containing protein, unsaturated fatty acid, dietary fiber, carbohydrate, VitAVitE,
Vitamin B1, vitamin B2, niacin, carrotene, potassium element, P elements, magnesium elements, calcium constituent, iodine, ferro element, selenium
The ingredients such as element, Zn-ef ficiency, oligosaccharide, saponin(e, phosphatide, nucleic acid, isoflavones.
Unsaturated fatty acid and soybean lecithin can reduce serum cholesterol, can protect blood vessel, prevent artery sclerosis, also
It being capable of brain tonic, prevention fatty liver.
In addition, dietary fiber rich in soy meal, dietary fiber can stop for a long time in stomach, Ke Yizeng
Add satiety, help to lose weight, and dietary fiber can also promote defecation, relief of constipation and acne.
The enough protein that soyabean protein powder provides can provide portion of energy consumed by body, for infant, blueness
Teenager, pregnant woman are that histone is maintained to update a critically important health care product for old man.Protein can effectively improve blood plasma
Cholesterol level, to reduce heart disease probability.For many men at an advanced age, supplement protein appropriate can prevent
There is no side effects for heart disease.
Soyabean protein powder can also provide various amino acid, can be the tissue of body substitute necrosis, reduce plasma cholesterol
Level, arginine be additionally favorable for injury healing.
Contain lecithin in soyabean protein powder, which is cell membrane, brains, the main composition substance of nerve fiber, food
Be conducive to enhance memory with albumen powder, senile dementia can also be prevented.The daidzin contained in albumen powder can more have with skin
Elasticity, it is brighter and cleaner, it can play the role of delaying senescence, beautifying face and moistering lotion.
Leaf of Moringa originates in the leaf of the perennial tropical deciduous tree Moringa tree (also known as drumstick tree) of India, has
Hypoglycemic, lipid-loweringing, decompression, antitumor, anti-oxidant, defaecation, diuresis, expelling parasite, improvement sleep and other effects, long-term consumption can enhance people
Body immunity function, anti-aging, prevention disease.It further, can also strengthen immunity, toxin expelling, body shaping, anti-aging, anticancer, simultaneously
Having to a variety of chronic and major disease greatly improves effect.
For leaf of Moringa as a kind of natural green food, the complete nutrients matter containing needed by human body may replace compound dimension
Raw element, calcium tablet, cod-liver oil etc., especially have good effect to hypertension, hyperlipidemia, diabetes, gout etc., play assistance prevention
Disease improves sleep, enhancing memory, delays senescence, and can be used to the disease for treating the privileged sites such as liver, spleen, channels and collaterals, also
Have the effects that treat halitosis and sober up.
Citrus powder can reconcile stomach, and stimulating intestine and stomach is wriggled, and help to be vented, alimentary canal of calming, and increase appetite, stimulation food
It is intended to.In addition, a large amount of dietary fibers being rich in citrus not only contribute to the wriggling of stomach, while may be used also using the pectin in citrus
Reduce the probability of cholesterol morbidity.
Citrus acid sweet in flavor, it is cool in nature, have effects that whet the appetite qi-regulating, moistening lung of quenching the thirst, for indigestion, thirsty and dry pharynx, does
Cough has certain therapeutic effect without diseases such as phlegm, while can also prevent cardiovascular disease and diabetes.Hesperidin in citrus can be with
Reinforce the toughness of capillary, blood pressure lowering expands the coronary artery of heart, and it is solid can to reduce the gallbladder being deposited in arteries
Alcohol helps that atherosclerosis is made to take a turn for the worse.
Contain dietary fiber and pectin in citrus, defaecation can be promoted, and cholesterol can be reduced.Research confirmation, mandarin orange
Also contain the very strong substance of a kind of anticancer activity " Nuo meter Ling " in orange juice liquid, it can be such that carcinogenic chemical decomposes, and inhibit and hinder
The growth of disconnected cancer cell, moreover it is possible to make one to prevent damage of the carcinogenic substance to nucleus, protection except the activity of toxenzyme significantly improves in vivo
Gene it is intact.
Oligofructose can reduce the content of cholesterol in serum and triglycerides as a kind of food additives, promote battalion
Feeding absorption (the especially absorption of calcium) prevents and treats diarrhea and constipation.It cannot directly be digested and assimilated by human body, and can only be by enteron aisle
Bacterium is absorbed and utilized, and has the characteristics that calorific value is low, is good sweetener.In addition, it is also to the selective proliferation of enteron aisle beneficial bacteria
Effect, makes profitable strain take advantage in enteron aisle, inhibits the growth of harmful bacteria, reduces noxious material (such as endotoxin, Ammonia
Deng) formation, there is protective effect to intestinal mucosa cells and liver, to prevent the generation of lesion intestinal cancer, enhance immunity of organisms.
Contain a large amount of ferro elements in celery, can more be avoided that dry skin with blood-nourishing, keep lustrous eyes, hair shiny black.Celery
Dish also has clearing heat and detoxicating effect.Especially dry in autumn, people often feel mouth parched and tongue scorched, upset, this
When proper amount of edible celery can play the effect of affectionate removing toxic substances.
The substance of a kind of lignin or enteral rouge can be generated in celery by gastric digestion rich in cellulose, this substance is
A kind of good antioxidant can effectively inhibit the carcinogen of enteral to grow, and then have the function that cancer-resisting.
The acidic materials isolated in celery can fight booster reaction caused by nicotine, mountain stalk theophylline, to involutional height
Hypotensive symptoms have special effect.The alkaline matter separated in celery has calm effect to animal, then has sedative action for human body.
It is also rich in the ingredient of diuresis in celery, can effectively remove internal water-sodium retention, then play the role of inducing diuresis to remove edema.
Inulin is that one kind not will lead to the raised carbohydrate of glucose in urine.It will not be hydrolyzed on the top of enteron aisle
At monosaccharide, because without increasing blood glucose level and insulin content.Nowadays studies have shown that the reduction of fasting blood-glucose is oligofructose
The result of the short chain fatty acids caused by colon fermentation.
Inulin can also greatly improve the absorption of the minerals such as Ca2+, Mg2+, Zn2+, Cu2+, Fe2+, and dietary fiber is disappearing
Change road energy bind metal ion.Any inulin and mineral complex are degraded in fermentation, release minerals, thus make
Metal ion is effectively absorbed.In addition, the acid caused by fermenting reduces pH value l to 2 unit of colon, make many mines
Solubility/biological effectiveness (such as calcium phosphate) of substance greatly improves.Moreover, studies have shown that short chain fatty acids, especially fourth
Hydrochlorate can stimulate the growth of colonic mucosal cells, improve the absorbability of intestinal mucosa.Inulin can also improve certain section of colon calcium to egg
The combination of white matter.
Studies have shown that inulin of ingesting daily can be such that the beneficial bacterium in colon increases significantly (about 10 times), reduce pathogen and
Spoilage organisms, such as salmonella, Listeria, staphylococcus aureus, coliform.Its mechanism is that inulin is not digested absorption
And be directly entered large intestine and preferentially utilized by Bifidobacterium, acetate and lactate are generated, the pH value of large intestine is reduced, to inhibit
The growth of harmful bacteria.So inulin is the proliferation factor of Bifidobacterium.Dietary fiber reduces food in the stop of stomach and intestine
Between, and increase excrement amount, effectively treat constipation.Its antiobesity action be improve content viscosity, reduce food from stomach into
Enter the speed of small intestine, to reduce hunger, reduces the food ration of food.
Circle bud isapgol husk is the Plantaginaceae of artificial growth, the luxuriant Chinese herbaceous peony (Classification system: Plantago of Plantago circle
Ovata) the shell of seed is widely used in drug, health care product, food, beverage and feeding because being rich in soluble dietary fiber
Expect in product.Its with relax bowel and defecation, prevent cardiovascular disease, help function of intestinal canal, prevent colon cancer and other gastrointestinal diseases
Suffer from probability, diabetes-glycemic control, prevention diverticulitis and control weight.
Embodiment 2:
The second chamber may include cocoa power, the luxuriant Chinese herbaceous peony shell powder of circle, soy meal, leaf of Moringa powder, trehalose, wheat
Powder, inulin, apple powder, soyabean protein powder and pineapple powder.Wherein, count by weight percentage, the raw material of the second chamber
Component ratio is as follows: cocoa power 23~25%；Circle bud Chinese herbaceous peony shell powder 10~18%；Soy meal 10~15%；Leaf of Moringa powder 8~
12%；Trehalose 8~12%；Wheat flour 6~10%；Inulin 4~6%；Apple powder 2~6%；Soyabean protein powder 1~3% and
Pineapple powder 4~6%.
According to the needs of actual conditions, those skilled in the art can select collocation within the above range to obtain described the
Two compositions.
Preferably, count by weight percentage, the second chamber is by the following raw material at being grouped as: cocoa power 25%；Circle
Luxuriant Chinese herbaceous peony shell powder 15%；Soy meal 12%；Leaf of Moringa powder 10%；Trehalose 10%；Wheat flour 8%；Inulin 5%；Apple powder
4%；Soyabean protein powder 1% and pineapple powder 5%.Amazing discovery, can using the second chamber that said components match
To obtain optimal health-care effect.
Wherein, protein, oleic acid, linoleic acid, stearic acid, palmitic acid, vitamin A, vitamin D, dimension are contained in cocoa power
Raw element E, vitamin B1, vitamin B2, vitamin B6, calcium constituent, magnesium elements, potassium element, sodium element, copper, ferro element, zinc
The ingredients such as element, cellulose, cocoa polyphenol, procyanidine, catechin, tannin, phenyl ethylamine, theobromine.
Linoleic acid has the function of vasodilator, eliminates dysbolism, helps insulin work, can be with stabilizing blood sugar, control
Appetite processed.Vitamin A is able to maintain that normal vision function, the health for safeguarding Epithelial cell, bone is maintained normally to grow
Development.
In addition, the tannin and cocoa polyphenol that contain in cocoa power, can prevent the formation of gum calculus and decayed tooth, for protecting
Shield tooth has good help.Flavonoid substances can promote vasodilation such as flavanols and procyanidine, and it is anti-to reduce inflammation
It should be formed with blood clot is reduced, to play the role of preventing cardiovascular disease.Phenyl ethylamine ingredient can make being in a cheerful frame of mind for people, the heart
Feelings are low, depressed person is edible can improve mood.
Trehalose, can be in cell surface energy under the severe environmental conditions such as high temperature, high and cold, hyperosmosis and dry dehydration
Unique protective film is formed, protein molecule invariance inactivation is effectively protected, thus the life process and life of the body that sustains life
Object feature.
Trehalose in addition to can be used as the excellent activity protective agent of pharmaceutical grade protein, enzyme, vaccine and other biological product with
Outside, it is also to maintain the important component of cell activity, moisturizing class cosmetics, more can be used as prevents food deterioration, keeps food fresh
Flavor, the particular foodstuff ingredient for promoting food quality, have expanded function of the trehalose as natural edible sweet taste sugar significantly.
Zn-ef ficiency rich in apple, Zn-ef ficiency are the synthetic ingredients of a variety of important enzymes in human body, immune with improving
Power, generating antibody has substantial connection, is key element needed for growth in humans's development.
Contain a large amount of phosphorus and ferro element in apple, be easy to be absorbed by intestinal wall, and the fragrance of apple is treatment depression
Good medicine can help to eliminate uneasy depressive emotion, play the role of cerebral tonic tranquillizing blood-nourishing.In addition, potassium element and people in apple
Superfluous sodium salt combines in body, excludes it external, is conducive to balance cylinder electrolyte.
Also contain polysaccharide tartaric acid and flavonoids, potassium element, vitamin C, the nutritional ingredients such as vitamin E, Neng Goubang in apple
Fat extra in decomposer is helped, body is avoided excessively to get fat, mitigates heart burden.And the tartaric acid and vitamin being rich in make one
Skin becomes fine and smooth, moist, helps that senile plaque is delayed to occur.Reduce cholesterol.
Pineapple contains the acid butyl ester for giving out tempting fragrance as common fruit, can exciting salivary secretion promotion food
It is intended to, crude fibre abundant, promotes gastrointestinal peristalsis, help digest, to promote appetite.
Edible pineapple can reduce blood lipid, antithrombotic.It is rich in a large amount of potassium, calcium and sugar, can play
The effect of inducing diuresis to remove edema, it is suitble to hypertension, nephritic dropsy and cough ant phlegm person are edible.
Bromelain is unique substance in pineapple, can dissolve fibrin and thrombus in blood vessel, improve local
Blood circulation.Pineapple contains a large amount of plant fibers, advantageously reduces the absorption of fat, moreover it is possible to promote enterogastric peristalsis, prevent constipation.
Bromelain can also effectively remove the dirt of dental surface, make tooth brilliant white.
Embodiment 3:
The third composition may include the luxuriant Chinese herbaceous peony shell powder of circle, soy meal, leaf of Moringa powder, wheat flour, trehalose, apple
Powder, soyabean protein powder, lemon powder, lactobacillus acidophilus and bifidobacterium longum.Wherein, count by weight percentage, the third group
The material composition ratio for closing object is as follows: circle bud Chinese herbaceous peony shell powder 22~26%；Soy meal 18~22%；Leaf of Moringa powder 8~12%；
Wheat flour 8~12%；Trehalose 6~10%；Apple powder 6~10%；Soyabean protein powder 6~10%；Lemon powder 4~7%；Acidophilus
Lactobacillus 2~4% and bifidobacterium longum 1~3%.
According to the needs of actual conditions, those skilled in the art can select collocation within the above range to obtain described the
Three compositions.
Preferably, count by weight percentage, the third composition is by the following raw material at being grouped as: circle bud Chinese herbaceous peony shell powder
25%；Soy meal 20%；Leaf of Moringa powder 10%；Wheat flour 10%；Trehalose 8%；Apple powder 8%；Soyabean protein powder 8%；Lemon
Lemon powder 6%；Lactobacillus acidophilus 3% and bifidobacterium longum 2%.
Amazing discovery can obtain optimal health-care effect using the third composition that said components match.Match
A variety of probiotics are closed to obtain the effect for promoting intestines peristalsis and relax bowel and defecation.
Wherein, citric acid contains a large amount of vitamin C, this constituents can enhance human body to irony in food after intake
Absorbability, have blood tonification effect.In addition, vitamin C is to promote wound healing, the weight of bone, tissue and cartilage health is kept
One of nutrient is wanted, helps to neutralize free radical, inhibits internal inflammation.Vitamin C can also help Amino acid synthesis collagen, protection
Skin prevents wrinkle early raw.
Lemon is rich in vitamin C, carbohydrate, calcium, phosphorus, iron, vitamin B1, vitamin B2, niacin, quininic acid, citric acid, apple
Tartaric acid, aurantiamarin, aurantiin, coumarin, a large amount potassium element and low amounts sodium element etc..These vitamins have very strong anti-oxidant
Effect, it is largely effective to the metabolism, anti-aging and inhibition pigmentation for promoting skin etc..Vitamin C and citrin energy
Enhance blood vessel elasticity and toughness, hypertension and myocardial infarction symptoms can be prevented and treated.
Lactobacillus acidophilus can be used for adjusting intestinal flora balance, inhibit the proliferation of enteron aisle undesirable microorganism.Acidophilus cream bar
Bacterium has antagonism to pathogenic microorganisms.Lactobacillus acidophilus can secrete antibiotin substance (acidolin
(acidolin), bacillus acidophilus's element (acidophilin), lactein (1aetocidon)).
Bifidobacterium longum is also one kind of probiotics, has and body is protected by the infection of pathogen, not inhibit enteral corruption
The case where, manufacture vitamin prevents and treats diarrhea, improves the immunity of body and decomposes the effect of carcinogen.
Embodiment 4:
Fig. 1 is the preparation method that intestines provided in an embodiment of the present invention arrange health care product.As shown in Figure 1, intestines row's health care product can
It is prepared with step with the following method:
110, raw material are pre-processed.The pretreatment can be the preprocessing process of any suitable type, including clear
Wash and be broken for the operation such as fragment.
120, according to corresponding weight percent, required material composition is weighed.
130, in stirring container, maltodextrin and oligofructose is added, stirs evenly.
140, in Xiang Suoshu stirring container, wheat seedling, soybean, leaf of Moringa, celery, chrysanthemum and the luxuriant Chinese herbaceous peony shell of circle is added
Powder, and stir evenly to prepare the first chamber.
150, the first chamber is independently encapsulated in laminated aluminum film bag according to the weight of every packet 10g.
160, the luxuriant Chinese herbaceous peony shell powder of cocoa power, circle, soy meal, leaf of Moringa powder, trehalose, small is sequentially added in stirring container
Flour, inulin, apple powder, soyabean protein powder and pineapple powder, and stir evenly to prepare the second chamber.
170, the second chamber is independently encapsulated in laminated aluminum film bag according to the weight of every packet 10g.
180, the luxuriant Chinese herbaceous peony shell powder of circle, soy meal, leaf of Moringa powder, wheat flour, trehalose, apple are sequentially added in stirring container
Fruit powder, soyabean protein powder and lemon powder simultaneously stir evenly.
190, the probiotics such as lactobacillus acidophilus and bifidobacterium longum are added in stirring container, prepare institute after mixing evenly
State third composition.
200, the third composition is independently encapsulated in laminated aluminum film according to the weight of every packet 10g~35g
In bag.
In some embodiments, the corresponding raw material powder of solid material can be obtained using modes such as grindings.In order to guarantee
The mouthfeel of health care product and health-care effect etc. preferably can also pass through specific mesh number before stirring container is added in raw material powder
Sieve is screened, to obtain powder particle of uniform size.
It, can according to the technique and scheme of the present invention and this hair it is understood that for those of ordinary skills
Bright design is subject to equivalent substitution or change, and all these changes or replacement all should belong to the guarantor of appended claims of the invention
Protect range.
Claims (10)
1. a kind of intestines arrange health care product, which is characterized in that be made of first chamber, second chamber and third composition；
The first chamber is wheat seedling composite enzyme, and the second chamber is cocoa composite enzyme, the third combination
Object is yogurt composite enzyme.
2. intestines according to claim 1 arrange health care product, which is characterized in that the first chamber, the second chamber
And the third composition is powdered solid beverage, individual packages are in laminated aluminum film bag.
3. intestines according to claim 2 arrange health care product, which is characterized in that the first chamber includes maltodextrin, small
Wheat seeding, soy meal, soyabean protein powder, leaf of Moringa powder, citrus powder and oligofructose.
4. intestines according to claim 3 arrange health care product, which is characterized in that the first chamber further include: celery, inulin
And the luxuriant Chinese herbaceous peony shell powder of circle.
5. intestines according to claim 4 arrange health care product, which is characterized in that count by weight percentage, first combination
Object is by the following raw material at being grouped as:
6. intestines according to claim 2 arrange health care product, which is characterized in that the second chamber includes: cocoa power, circle bud
Chinese herbaceous peony shell powder, soy meal, leaf of Moringa powder, trehalose, wheat flour, inulin, apple powder, soyabean protein powder and pineapple powder.
7. intestines according to claim 6 arrange health care product, which is characterized in that count by weight percentage, second combination
Object is by the following raw material at being grouped as:
8. intestines according to claim 2 arrange health care product, which is characterized in that the third composition includes: the luxuriant Chinese herbaceous peony shell of circle
Powder, soy meal, leaf of Moringa powder, wheat flour, trehalose, apple powder, soyabean protein powder and lemon powder.
9. intestines according to claim 8 arrange health care product, which is characterized in that the third composition further include: acidophilus cream bar
Bacterium and bifidobacterium longum.
10. intestines according to claim 9 arrange health care product, which is characterized in that count by weight percentage, the third combination
Object is by the following raw material at being grouped as:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910260830.0A CN110089751A (en) | 2019-04-02 | 2019-04-02 | Intestines arrange health care product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910260830.0A CN110089751A (en) | 2019-04-02 | 2019-04-02 | Intestines arrange health care product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110089751A true CN110089751A (en) | 2019-08-06 |
Family
ID=67444270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910260830.0A Pending CN110089751A (en) | 2019-04-02 | 2019-04-02 | Intestines arrange health care product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110089751A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111317082A (en) * | 2020-01-03 | 2020-06-23 | 深圳市淳睿科技发展有限公司 | Vegetable and fruit composition beverage and preparation method thereof |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102396659A (en) * | 2011-11-11 | 2012-04-04 | 完美（中国）有限公司 | Health-care food with defaecating function and preparation method thereof |
| CN105211687A (en) * | 2015-10-20 | 2016-01-06 | 汤臣倍健股份有限公司 | A kind of composition and method of making the same and purposes |
| CN106465946A (en) * | 2016-09-19 | 2017-03-01 | 江苏慧博生物科技有限公司 | A kind of loosening bowel to relieve constipation dietary fiber |
| CN106605919A (en) * | 2016-11-01 | 2017-05-03 | 西安源森生物科技有限公司 | Composition used for removing food retention and relaxing bowels of children, as well as preparation method thereof |
| CN106954847A (en) * | 2017-03-30 | 2017-07-18 | 广州能靓生物技术有限公司 | Ferment probiotic composition with function of relaxing bowel, using and process preparation |
| WO2018181380A1 (en) * | 2017-03-28 | 2018-10-04 | 株式会社アドバンス | Edible composition for intestinal bacteria |
| CN108968058A (en) * | 2018-09-17 | 2018-12-11 | 广州乔媛商贸有限公司 | It is a kind of improve enteron aisle probiotics enzyme composition and application |
| CN109007516A (en) * | 2018-10-15 | 2018-12-18 | 天津康利益生食品科技有限公司 | Composite fruit and vegetable solid beverage and its preparation and application |
| CN109497386A (en) * | 2018-12-26 | 2019-03-22 | 厦门泰好保健食品有限公司 | A kind of vegetable solid drink composition improving enteron aisle digestion |
-
2019
- 2019-04-02 CN CN201910260830.0A patent/CN110089751A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102396659A (en) * | 2011-11-11 | 2012-04-04 | 完美（中国）有限公司 | Health-care food with defaecating function and preparation method thereof |
| CN105211687A (en) * | 2015-10-20 | 2016-01-06 | 汤臣倍健股份有限公司 | A kind of composition and method of making the same and purposes |
| CN106465946A (en) * | 2016-09-19 | 2017-03-01 | 江苏慧博生物科技有限公司 | A kind of loosening bowel to relieve constipation dietary fiber |
| CN106605919A (en) * | 2016-11-01 | 2017-05-03 | 西安源森生物科技有限公司 | Composition used for removing food retention and relaxing bowels of children, as well as preparation method thereof |
| WO2018181380A1 (en) * | 2017-03-28 | 2018-10-04 | 株式会社アドバンス | Edible composition for intestinal bacteria |
| CN106954847A (en) * | 2017-03-30 | 2017-07-18 | 广州能靓生物技术有限公司 | Ferment probiotic composition with function of relaxing bowel, using and process preparation |
| CN108968058A (en) * | 2018-09-17 | 2018-12-11 | 广州乔媛商贸有限公司 | It is a kind of improve enteron aisle probiotics enzyme composition and application |
| CN109007516A (en) * | 2018-10-15 | 2018-12-18 | 天津康利益生食品科技有限公司 | Composite fruit and vegetable solid beverage and its preparation and application |
| CN109497386A (en) * | 2018-12-26 | 2019-03-22 | 厦门泰好保健食品有限公司 | A kind of vegetable solid drink composition improving enteron aisle digestion |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111317082A (en) * | 2020-01-03 | 2020-06-23 | 深圳市淳睿科技发展有限公司 | Vegetable and fruit composition beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101473953B (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
| CN104643250B (en) | It is a kind of can bidirectional modulation body weight improve inferior health solid beverage | |
| KR101018065B1 (en) | Method for manufacturing health drink using jujube leaf and health drink manufactured by this | |
| CN102077937A (en) | Special dietary seafood special for young and middle-aged women | |
| CN101396115B (en) | Xylo-oligosaccharide stomach-invigorating intestine-moisturizing oral liquid and preparation method thereof | |
| CN111543605A (en) | Comprehensive nutrition powder for people with hypertension, hyperlipidemia and obesity | |
| KR19990084077A (en) | Low Sugar Functional Foods to Improve Obesity | |
| CN102511876B (en) | Hawthorn red jujube thick syrup and production process thereof | |
| KR20080090808A (en) | Composition of healthy food for a skin | |
| CN110089751A (en) | Intestines arrange health care product | |
| CN109730222A (en) | Ferment complex liquid and its health drink | |
| CN105249475A (en) | Health care alga agar-agar jelly and preparation method of health care alga agar-agar jelly | |
| CN109452417A (en) | A kind of pure natural fat eliminating Weight reducing tea drink and preparation method thereof | |
| KR101253342B1 (en) | Composition Vitamin With Dry Laver | |
| CN110089754A (en) | Liver and gallbladder health care product | |
| CN113749152A (en) | Health preserving and body building drink and preparation method thereof | |
| CN102511882A (en) | Red jujube thick syrup beneficial for improving growth and development | |
| JP2009034017A (en) | Diet food | |
| KR100475628B1 (en) | Healthful food on the base trepang manufacturing method | |
| CN110393246A (en) | A kind of oyster drink production method facilitating men's health | |
| CN104223201A (en) | Enteromorpha eight-ingredient porridge | |
| CN108967757A (en) | A kind of thickened red jujube ginger pulp production technology | |
| KR20060079777A (en) | Emotional tea with spicy, sweety collagen vita kiwi green tea | |
| CN107996900A (en) | The long beverage of children's stomach invigorating furtherance | |
| CN109730313A (en) | Assist canteen composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190806 |